Revisiting the Medical Management of Parkinson's Disease: Levodopa versus Dopamine Agonist

The optimal treatment strategy for Parkinson's disease has been debated for decades. The introduction of levodopa (LD) treatment is frequently delayed because of theoretical concerns about its toxicity or the risk of drug-induced motor complications. These concerns have resulted in “LD phobia”...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jinglin, Tan, Louis Chew-Seng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876591/
https://www.ncbi.nlm.nih.gov/pubmed/26644151
http://dx.doi.org/10.2174/1570159X14666151208114634

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876591/
https://www.ncbi.nlm.nih.gov/pubmed/26644151
http://dx.doi.org/10.2174/1570159X14666151208114634

Ejemplares similares